Evidence map›Paper›PMID 27052467›Full record

ArticleThrombosis and haemostasis2016

The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding.

D'Andra N Parker, Subia Tasneem, Richard W Farndale, Dominique Bihan, J Evan Sadler, Silvie Sebastian, Philip G de Groot, Catherine P M Hayward

Open access · hybridAbstract read
In one paragraph

Article in Thrombosis and haemostasis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Multimerin-1 and cancer: a review.Bioscience reports · 2022
    Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

D'Andra N Parker
Subia Tasneem
Richard W Farndale
Dominique Bihan
J Evan Sadler
Silvie Sebastian
Philip G de Groot
Catherine P M HaywardCatherine P. M. Hayward, McMaster University Medical Centre, HSC 2N29A, 1200 Main St. West, Hamilton, Ontario, Canada L8N 3Z5, Tel.: +1 905 521 2100 Ext. 76274, Fax: +1 905 521 2338, E-mail: haywrdc@mcmaster.ca.
University Medical Center Utrecht · NLUniversity of Cambridge · GBHamilton Regional Laboratory Medicine Program · CAMcMaster University · CAWashington University in St. Louis · US

Funding

Translational Research Skills Development CoreU54HL112303 · NHLBI · WASHINGTON UNIVERSITY · PI SADLER, J EVAN · 2012 to 2016
$8.8M
VON WILLEBRAND FACTOR MULTIMER ASSEMBLY AND STRUCTURER01HL072917 · NHLBI · WASHINGTON UNIVERSITY · PI SADLER, J EVAN · 2003 to 2012
$4.4M
British Heart Foundation RG/09/003/27122British Heart Foundation RG/15/4/31268CIHRNHLBI NIH HHS R01 HL072917NHLBI NIH HHS U54 HL112303Wellcome Trust
6 · The paper itself

Abstract

Multimerin 1 (MMRN1) is a massive, homopolymeric protein that is stored in platelets and endothelial cells for activation-induced release. In vitro, MMRN1 binds to the outer surfaces of activated platelets and endothelial cells, the extracellular matrix (including collagen) and von Willebrand factor (VWF) to support platelet adhesive functions. VWF associates with MMRN1 at high shear, not static conditions, suggesting that shear exposes cryptic sites within VWF that support MMRN1 binding. Modified ELISA and surface plasmon resonance were used to study the structural features of VWF that support MMRN1 binding, and determine the affinities for VWF-MMRN1 binding. High shear microfluidic platelet adhesion assays determined the functional consequences for VWF-MMRN1 binding. VWF binding to MMRN1 was enhanced by shear exposure and ristocetin, and required VWF A1A2A3 region, specifically the A1 and A3 domains. VWF A1A2A3 bound to MMRN1 with a physiologically relevant binding affinity (KD: 2.0 ± 0.4 nM), whereas the individual VWF A1 (KD: 39.3 ± 7.7 nM) and A3 domains (KD: 229 ± 114 nM) bound to MMRN1 with lower affinities. VWF A1A2A3 was also sufficient to support the adhesion of resting platelets to MMRN1 at high shear, by a mechanism dependent on VWF-GPIbα binding. Our study provides new information on the molecular basis of MMRN1 binding to VWF, and its role in supporting platelet adhesion at high shear. We propose that at sites of vessel injury, MMRN1 that is released following activation of platelets and endothelial cells, binds to VWF A1A2A3 region to support platelet adhesion at arterial shear rates.

Indexed as

Blood PlateletsBlood ProteinsEnzyme-Linked Immunosorbent AssayHumansIn Vitro TechniquesMicrofluidic Analytical TechniquesMutant ProteinsPlatelet ActivationPlatelet AdhesivenessPlatelet Glycoprotein GPIb-IX ComplexProtein BindingProtein DomainsRecombinant ProteinsRistocetinSurface Plasmon Resonancevon Willebrand Factoradhesion receptorBlood ProteinsmultimerinMutant ProteinsPlatelet Glycoprotein GPIb-IX ComplexRecombinant ProteinsRistocetinvon Willebrand Factoradhesion moleculescollagensplatelet glycoproteinsvon Willebrand factor

Identifiers

PMID27052467
PMCPMC5175582
OpenAlexW2324161651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.